Committee
Consult the user guide
For assistance, please contact us
Consult the user guide
For assistance, please contact us
Add search criteria
Results: 1 - 15 of 659
View Ujjal Dosanjh Profile
Lib. (BC)
Thank you very much Madam Chair.
Thank you, Madam Minister, for being here.
I have five or six questions. I'm sure I won't finish the 15 minutes, and my colleagues can share the time with me.
Minister, at the end of your remarks you raised the issue of the statutory review. The question I have is, if you're so inclined now that this committee should do the review, what was the intent and motivation behind sending it to the Senate in the first place?
View Ujjal Dosanjh Profile
Lib. (BC)
And did you think this committee wasn't capable of doing as good a job or better?
View Ujjal Dosanjh Profile
Lib. (BC)
I understand that. Please answer the question.
View Ujjal Dosanjh Profile
Lib. (BC)
Please answer the question.
View Ujjal Dosanjh Profile
Lib. (BC)
That's not your motion.
View Ujjal Dosanjh Profile
Lib. (BC)
Yes, I understand that, but please answer the question. Did you think this committee wasn't capable of doing that job at that time? Have you changed your mind now?
View Ujjal Dosanjh Profile
Lib. (BC)
Now, in the budget it specifically mentions that the government is providing a 6% increase to the health transfers. Can you confirm that is the increase that's embedded in the 2004 accord, that the 6% you are providing is nothing more than what was agreed to between the Prime Minister and the premiers in 2004?
View Ujjal Dosanjh Profile
Lib. (BC)
I understand that.
View Ujjal Dosanjh Profile
Lib. (BC)
Thank you very much.
I'm trying to save time. I'm asking very brief questions.
Now, I see that there is no money in the budget anywhere that is dedicated to the commencement of a national pharmacare plan or a national pharmaceutical strategy. You know, Minister, that in the 2004 accord there is a specific provision, which is titled “national pharmaceutical strategy”. It talks about cost options for catastrophic coverage, a common national drug formulary, access to break-through drugs, and many other things. Have there been any discussions since you took over as Minister of Health on that portion of the accord with any of the governments in Canada?
View Ujjal Dosanjh Profile
Lib. (BC)
Have you ever discussed with the ministers of health the establishment of a common national drug formulary, as was envisioned in the accord, and when was that?
View Ujjal Dosanjh Profile
Lib. (BC)
View Ujjal Dosanjh Profile
Lib. (BC)
And those conversations were based on the national pharmaceutical strategy, with the intention of providing the kind of coverage it talks about, or were they just isolated discussions?
View Ujjal Dosanjh Profile
Lib. (BC)
At what meeting of the ministers did that discussion take place?
View Ujjal Dosanjh Profile
Lib. (BC)
What meeting of the ministers—
View Ujjal Dosanjh Profile
Lib. (BC)
—did specifically discuss the national pharmaceutical strategy?
Results: 1 - 15 of 659 | Page: 1 of 44

1
2
3
4
5
6
7
8
9
10
>
>|
Export As: XML CSV RSS

For more data options, please see Open Data